Minova Life Science

Minova life sciences - Pharmaceutical company

Promoto-200 Softgel

A promise for Happy Tomorrow


COMPOSITION – Micronized Progesterone  200mg

  • More effective in providing luteal support in comparison to intra-vaginal progesterone in patients undergoing IVF-embryo transfer cycles.
  • Decreases the frequency of uterine contractions & rate of preterm delivery in women with high risk of prematurity.
  • Increases endometrial thickness thus enhances receptivity for implantation.
  • Reduces birth defects in babies exposed to synthetic progesterone.


  • Luteal Phase Defect
  • Pre-term delivery
  • Habitual Abortion
  • Threatened Abortion

Promoto-200 Softgel



  • Provides relief from recurrent miscarriage due to luteal Phase deficiency.
  • Eliminates the endometrial risk with estrogen. replacement theraphy.
  • Relieves vasomotor symptoms, sleep disturbances, and vaginal dryness.
  • Helps in regulation of the menstrual cycle & dysfunctional uterine bleeding.
  • Effective in inducing withdrawal bleeding in women with secondary amenorrhea.

Explore other products

Scroll to Top